It seems clear that the end of the quarter has for
Post# of 154863
(Total Views: 633)
Posted On: 03/30/2022 3:57:49 PM
It seems clear that the end of the quarter has forced the management of Cytodyn to end their silence, a silence they probably would have extended longer if they could have.
But now it is time to put some good news on the books, to balance out the otherwise probably less-than-cheery news from the quarter, something that will show up in the upcoming 10-Q which, no doubt, would not be pretty otherwise.
Part of the motive might also be to make some claim on performance bonuses if the share price rockets up. Scheduling the webcast before the market opening seems to indicate the impact of their news for us shareholders is positive and momentous.
If the news management presents is not that impactful yet, I expect them to say that positive, impactful news will be coming soon. How could it be otherwise? Many things the company is doing are maturing. Everyone here knows what they are -
HIV BLA
BTD filings
Mid-point of Brazil trials and DSMB reports
NASH results
mTNBC filings
Results of the Amarex audit and the state of our data from CD10 and CD12 trials
etc.
I am not interested in BO or partnership talk unless it is of the magnitude we as shareholders would actually vote for. SHOW ME THE MONEY - otherwise, go away!
I would love to hear of a limited licensing agreement with someone like Samsung for all indications in a limited market and a wad of upfront money for that privilege. That would leave Cytodyn and its intellectual property intact and would reveal Cytodyn's true worth. Wanna buy us out now, BP?
The most important thing that can come out of the webcast tomorrow is an increase in the share price. We can't do much of anything without that - our finances and everything else will be based on that. If we begin the climb of our share price that we all desire, we can move to a major exchange and our future will be extremely bright.
So tomorrow, hopefully, Cytodyn's silence will be broken by a thunderclap! - or at least some sheet lightning. Then may we reach escape velocity from the gravity that has brought us so low!
But now it is time to put some good news on the books, to balance out the otherwise probably less-than-cheery news from the quarter, something that will show up in the upcoming 10-Q which, no doubt, would not be pretty otherwise.
Part of the motive might also be to make some claim on performance bonuses if the share price rockets up. Scheduling the webcast before the market opening seems to indicate the impact of their news for us shareholders is positive and momentous.
If the news management presents is not that impactful yet, I expect them to say that positive, impactful news will be coming soon. How could it be otherwise? Many things the company is doing are maturing. Everyone here knows what they are -
HIV BLA
BTD filings
Mid-point of Brazil trials and DSMB reports
NASH results
mTNBC filings
Results of the Amarex audit and the state of our data from CD10 and CD12 trials
etc.
I am not interested in BO or partnership talk unless it is of the magnitude we as shareholders would actually vote for. SHOW ME THE MONEY - otherwise, go away!
I would love to hear of a limited licensing agreement with someone like Samsung for all indications in a limited market and a wad of upfront money for that privilege. That would leave Cytodyn and its intellectual property intact and would reveal Cytodyn's true worth. Wanna buy us out now, BP?
The most important thing that can come out of the webcast tomorrow is an increase in the share price. We can't do much of anything without that - our finances and everything else will be based on that. If we begin the climb of our share price that we all desire, we can move to a major exchange and our future will be extremely bright.
So tomorrow, hopefully, Cytodyn's silence will be broken by a thunderclap! - or at least some sheet lightning. Then may we reach escape velocity from the gravity that has brought us so low!
(6)
(0)